Received 09/01/2022 review began 09/08/2022 review ended 09/19/2022 published 09/26/2022

HIGHLIGHTS

• who: Report et al. from the Center, Dothan, USA have published the paper: Received 09/01/2022 Review began 09/08/2022 Review ended 09/19/2022 Published 09/26/2022, in the Journal: (JOURNAL) of September/26,/2022
• what: IBCAs are medically necessary, but not without risk.
• future: Studies are required prior to any recommendations on which patients are most at risk for CIN. Research is needed to determine if IBCA toxicity is dose-dependent or idiopathic and to investigate the best practices associated with management and prevention.

SUMMARY

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.